SCHEMBL21975670

SCHEMBL21975670

CNc1cc(Oc2nc(-c3cccnc3)nc(N)c2C=N)ccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.40
▸ POLB P06746 3/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ PRKCA P17252 1/20 0.36
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21974762 0.84 MAPT (0.44) MAPTPOLBNPSR1RAB9ALMNA
SCHEMBL21975659 0.78 MAPT (0.37) MAPTPOLBNPSR1LMNAABCG2
SCHEMBL21975103 0.71 CYP1A2 (0.41) MAPTPOLBNPSR1RAB9APRKCA
SCHEMBL21975105 0.71 MEN1 (0.40) MAPTLMNASMN1; SMN2KDM4EHSD17B10
SCHEMBL21974920 0.70 ABCG2 (0.43) MAPTPOLBNPSR1RAB9ALMNA
SCHEMBL21975122 0.69 RAB9A (0.41) MAPTPOLBNPSR1RAB9AABL1
SCHEMBL22066072 0.68 CYP3A4 (0.59) MAPTNPSR1LMNASMN1; SMN2KDM4E
SCHEMBL21974789 0.67 RAB9A (0.41) MAPTPOLBNPSR1RAB9AABCG2
SCHEMBL21974781 0.66 MAPT (0.40) MAPTPOLBNPSR1LMNAABCG2
SCHEMBL21974948 0.66 CYP11B1 (0.34) MAPTPOLBABL1BCRPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3647313-A1 SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Xiamen University (CN) 2020-05-06 — — EP disclosed
Send feedback